Salts and Derivatives of Active Pharmaceutical Ingredients (API)
The salts of Active Pharmaceutical Ingredients (APIs) are compounds formed by the reaction of an acid with a base, resulting in an ionic equilibrium. These salts often improve the solubility and stability of APIs, facilitating their absorption in the body. API derivatives are chemical variants of an active ingredient that may have enhanced or modified properties to optimise therapeutic efficacy. API salts are used in the formulation of oral, injectable, and topical medications. Additionally, API derivatives can improve the pharmacokinetics of drugs, such as enabling controlled release of active substances.
At CymitQuimica, we provide API salts and derivatives with the necessary purity and quality for research and pharmaceutical formulation development.
Found 79238 products of "Salts and Derivatives of Active Pharmaceutical Ingredients (API)"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
N-(2,6-Dichlorophenyl)aniline
CAS:Controlled Product<p>Applications N-(2,6-Dichlorophenyl)aniline is an analog of Diclofenac (D436450), a nonsteroidal anti-inflammatory compound an decycloxygenase (COX) inhibitor.<br>References Moser, P. et al.: J. Med. Chem., 33, 2358 (1990); Encinas, S. et al.: Photochem. Photobiol., 68,640 (1998); Kenny, J. R., et al.: J. Med. Chem., 47, 2816 (2004), Sasaki, A., et al.: J. Pharmacol. Sci., 108, 266 (2008), Dalvie, D., et al.: Chem. Res. Toxicol., 22, 357 (2009),<br></p>Formula:C12H9Cl2NColor and Shape:WhiteMolecular weight:238.11E,E-Farnesylacetone
CAS:Controlled Product<p>Stability Light Sensitive<br>Applications E,E-Farnesylacetone, is a natural organic compound which is present in many essential oils. It has been shown that, Farnesylacetone inhibits electron transport in isolated rat liver mitochondria.<br>References Dupont, J. et al.: Biology of the Cell, 67(2), 141-146 (1989); Gaviria, M. et al.: Chem. & Biodiversity 8, 532 (2011)<br></p>Formula:C18H30OColor and Shape:NeatMolecular weight:262.4310-Hydroxy Warfarin(Mixture of Diastereomers)
CAS:Controlled ProductFormula:C19H16O5Color and Shape:NeatMolecular weight:324.33O-Desisobutyl-O-n-propyl Febuxostat
CAS:Formula:C15H14N2O3SColor and Shape:NeatMolecular weight:302.352-(4-(Methylsulfonamido)phenoxy)acetic Acid
CAS:Controlled Product<p>Applications 2-(4-(Methylsulfonamido)phenoxy)acetic Acid is a metabolite of antiarrhythmic drug Dofetilide (D525700), which is a is a potassium channel blocker.<br>References Smith, D., et al.: Xenobiotica, 22, 709 (1992); Carmeliet, D., et al.: J. Pharmacol. Exp. Ther., 262, 809 (1992); Walker, D., et al.: Drug Metab. Dispos., 24, 447 (1996); Norgaard, B.L., et al.: Am. Heart J., 137, 1062 (1999); Torp-Pedersen, C., et al.: N. Engl. J. Med. 341, 857 (1999);<br></p>Formula:C9H11NO5SColor and Shape:NeatMolecular weight:245.25(1S)-4,5-Dimethoxy-1-[(methylamino)methyl]benzocyclobutane Hydrochloride
CAS:Controlled ProductFormula:C12H17NO2·ClHColor and Shape:NeatMolecular weight:243.73(1R,2S)-2-(3,4-Difluorophenyl)cyclopropanamine Hydrochloride
CAS:Controlled Product<p>Applications (1R,2S)-2-(3,4-Difluorophenyl)cyclopropanamine is an intermediate used to prepare trans-2-arylcyclopropylamines as potent and selective dipeptidyl peptidase IV inhibitors.<br>References Tsai, T., et al.: Bioorg. Med. Chem., 17, 2388 (2009)<br></p>Formula:C9H9F2N·HClColor and Shape:Off White SolidMolecular weight:205.6323-Descyano Febuxostat
CAS:Controlled Product<p>Applications 3-Descyano Febuxostat is an impurity of Febuxostat (F229000), a xanthine oxidase/xanthine dehydrogenase inhibitor. Used for treatment of hyperuricemia and chronic gout. 40-120 mg/day febuxostat was proven effective in lowering serum urate levels when administered to manage hyperuricemia in patients with gout.<br>References Kadivar, M.H., et. al.: J. Pharmaceut. Biomed. Anal., 56, 749 (2011); Vallu, V., et. al.: Anal. Chem. Indian J., 14, 339 (2014); Osada, Y., et al.: Eur. J. Pharmacol., 241, 183 (1993); Okamoto, K., et al.: J. Biol. Chem., 278, 1848 (2003); Mayer, M.D., et al.: Am. J. Therap., 12, 22 (2005); Tomlinson, B., et al.: Curr. Opin. Invest. Drugs, 6, 1168 (2005)<br></p>Formula:C15H17NO3SColor and Shape:NeatMolecular weight:291.37Perindoprilat Lactam A
CAS:<p>Impurity Perindopril EP Impurity C<br>Applications Perindoprilat Lactam A (Perindopril EP Impurity C) is the active metabolite of Perindopril (P287500) in plasma and urine.<br>References Hillaert, S., et al.: J. Pharm. Biomed. Anal., 25, 775 (2001), Ozoemena, K., et al.: Talanta, 62, 681 (2004),<br></p>Formula:C17H26N2O4Color and Shape:White To BeigeMolecular weight:322.40
![(1S)-4,5-Dimethoxy-1-[(methylamino)methyl]benzocyclobutane Hydrochloride](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FD461760.webp&w=3840&q=75)
